Robin Swartz, COO & CBO at Voyager Therapeutics, Inc. (VYGR), sold 3,882 shares at $3.44 ($13K) on 2026-02-18, disclosed to the SEC on 2026-02-20.
Seasonal sale ($13k) by COO & CBO — this insider has traded VYGR in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| VYGR | SELL | 2025-02-24 | $17K | — | Filing → |
| VYGR | SELL | 2025-02-12 | $31K | — | Filing → |
| VYGR | SELL | 2025-01-15 | $16K | — | Filing → |